A detailed history of Rogco, LP transactions in Pfizer Inc stock. As of the latest transaction made, Rogco, LP holds 18,829 shares of PFE stock, worth $517,044. This represents 0.21% of its overall portfolio holdings.

Number of Shares
18,829
Previous 19,794 4.88%
Holding current value
$517,044
Previous $554 Million 1.61%
% of portfolio
0.21%
Previous 0.23%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$27.7 - $31.39 $26,730 - $30,291
-965 Reduced 4.88%
18,829 $545 Million
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $7,325 - $8,584
-290 Reduced 1.44%
19,794 $554 Million
Q1 2024

May 08, 2024

SELL
$25.89 - $29.73 $51,495 - $59,132
-1,989 Reduced 9.01%
20,084 $557 Million
Q4 2023

Feb 06, 2024

SELL
$26.13 - $33.94 $783 - $1,018
-30 Reduced 0.14%
22,073 $635 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $709,285 - $829,083
22,103 New
22,103 $733 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Rogco, LP Portfolio

Follow Rogco, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rogco, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rogco, LP with notifications on news.